Action of metronidazole in combination with isoniazid and rifampicin on persisting organisms in experimental murine tuberculosis

Indian Journal of Medical Research

Volumn 108, Issue OCT., 1998, Pages 115-119

  Paramasivan, C N ^a   Kubendiran, G ^a   Herbert, Daniel ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

Author keywords

Dormant bacilli; Metronidazole; Murine model; Mycobacterium tuberculosis; Persisters

Indexed keywords

ISONIAZID; METRONIDAZOLE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; LUNG; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; ORAL DRUG ADMINISTRATION; SPLEEN; TUBERCULOSIS;

ANIMALS; ANTITUBERCULAR AGENTS; DRUG THERAPY, COMBINATION; FEMALE; ISONIAZID; METRONIDAZOLE; MICE; MICE, INBRED BALB C; RIFAMPIN; TUBERCULOSIS;

EID: 0031725183     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Mitchison DA. Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months [letter]. Am Rev Respir Dis 1993; 147 : 1062-3.
2. Mitchison DA. Basic mechanisms of chemotherapy. Chest 1979; 76 : 6 Suppl. 771-81.
3. Narain JP, Raviglione MC, Kochi A. HIV-associated tuberculosis in developing countries : epidemiology and strategies for prevention. Tuber Lung Dis 1992; 73 : 311-21.
4. Raviglione MC, Narain JP, Kochi A. HIV-associated tuberculosis in developing countries : clinical features, diagnosis and treatment. Bull World Health Organ 1992; 70 : 515-26.
5. McCune RM Jr, Tompsett R, McDermott W. The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug. J Exp Med 1956; 104 : 763-802.
6. McCune RM, Feldmann FM, Lambert HP, McDermott W. Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues. J Exp Med 1966; 123 : 445-68.
7. McCune RM, Feldmann FM, McDermott W. Microbial persistence. II. Characteristics of the sterile state of tubercle bacilli. J Exp Med 1966; 123 : 469-86.
8. de Wit D, Wootton M, Dhillon J, Mitchison DA. The bacterial DNA content of mouse organs in the Cornell model of dormant tuberculosis. Tuberc Lung Dis 1995; 76 : 555-62.
9. Wayne LG, Sramek HA. Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis. Antimicrob Agents Chemother 1994; 38 : 2054-8.
10. Wayne LG. Dynamics of submerged growth of Mycobacterium tuberculosis under aerobic and microaerophilic conditions. Am Rev Respir Dis 1976; 114 : 807-11.
11. Wayne LG, Hayes LG. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect Immun 1996; 64 : 2062-9.
12. Canetti G, Fox W, Khomenko A, Mahler HT, Menon NK, Mitchison DA, et al. Advances in techniques of testing mycobacterial drug sensitivity and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 1969; 41 : 21-43.
13. Dickinson JM, Mitchison DA. Efficacy of intermittent pyrazinamide in experimental murine tuberculosis. Tubercle 1991; 72 : 110-4.
14. Taylor JA Jr, Migliardi JR, Wittenau MS. Tinidazole and metronidazole pharmacokinetics in man and mouse. Antimicrob Agents Chemother 1969 : 267-70.
15. Grosset J, Truffot-Pernot C, Bismuth R, Lecoeur H. Les donnecs recentes de la chimiotherapie de la tuberculose experimentale de la souris. Bull Int Union Tuberc 1983; 58 : 90-6.
16. Mitchison DA. The Garrod Lecture. Understanding the chemotherapy of tuberculosis-current problems. J Antimicrob Chemother 1992; 29 : 477-93.
17. Dickinson JM, Mitchison DA. Experimental models to explain the high sterilizing activity of rifampin in the chemotherapy of tuberculosis. Am Rev Respir Dis 1981; 123 : 367-71.